FDG-PET/CT in Evaluation and Prognostication of Primary Prostate Lymphoma

被引：9

作者：

Hodgson, Richard ^{[2
]}

Huang, Yi-Tung ^{[3
]}

Steinke, Karin ^{[2
]}

Kumar, Aravind S. Ravi ^{[1
,3
]}

机构：

[1] Royal Brisbane & Womens Hosp, Dept Nucl Med, Brisbane, Qld 4029, Australia

[2] Royal Brisbane & Womens Hosp, Dept Med Imaging, Brisbane, Qld 4029, Australia

[3] Queensland PET Serv, Brisbane, Qld 4029, Australia

来源：

CLINICAL NUCLEAR MEDICINE | 2010年 / 35卷 / 06期

关键词：

prostate; non-Hodgkin lymphoma; PET/CT; F-18; FDG; prognosis; NON-HODGKINS-LYMPHOMA; CARCINOMA; THERAPY;

D O I：

10.1097/RLU.0b013e3181db4eb7

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A 76-year-old man was incidentally diagnosed with prostate lymphoma following transurethral resection of the prostate for prostatism. Staging F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) revealed markedly increased FDG uptake in the prostate, with no evidence of other disease. Following combination chemotherapy, restaging FDG-PET/CT demonstrated a complete metabolic response. The patient subsequently achieved prolonged remission on follow-up. Because of its rarity, FDG-PET in predicting outcome after therapy has not been validated for primary prostate lymphoma. This case highlights the potential of FDG-PET/CT in not only evaluation of disease extent but also prognostication of primary lymphoma of the prostate. Copyright © 2010 by Lippincott Williams & Wilkins.

引用

页码：418 / 420

页数：3

共 13 条

[1] Early FDG-PET response-adapted risk stratification and further therapeutic decision-making in lymphoma: will this replace the established prognostic indices and be the standard-of-care in clinical management? [J].

Basu, Sandip .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (12) :2089-2090

[2]

Bostwick DG, 1998, CANCER, V83, P732, DOI 10.1002/(SICI)1097-0142(19980815)83:4<732::AID-CNCR15>3.0.CO

[3]

2-T

[4] Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy - A study of 29 cases [J].

Chu, PGG ;

Huang, Q ;

Weiss, LM .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (05) :693-699

[5]

Fukutani Keiko, 2003, Nihon Hinyokika Gakkai Zasshi, V94, P621

[6] High-grade urothelial carcinoma of the prostate on FDG PET-CT [J].

Ho, Linh ;

Quan, Vicki ;

Henderson, Robert ;

Seto, John .

CLINICAL NUCLEAR MEDICINE, 2007, 32 (09) :746-747

[7] Incidental Detection of Granulomatous Prostatitis by F-18 FDG PET/CT in a Patient with Bladder Cancer A Rare Complication of BCG Instillation Therapy [J].

Ilgan, Seyfettin ;

Koca, Gokhan ;

Gundogdu, Sadi .

CLINICAL NUCLEAR MEDICINE, 2009, 34 (09) :613-614

[8] FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma [J].

Kasamona, Yvette L. ;

Wah, Richard L. .

CURRENT OPINION IN ONCOLOGY, 2008, 20 (02) :206-219

[9] High levels of serum prostate-specific antigen due to PSA producing follicular non-Hodgkin's lymphoma [J].

Oosterheert, Jan Jelrik ;

Budel, Leo M. ;

Vos, Pieter ;

Wittebol, Shulamiet .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (02) :155-158

[10] PRIMARY LYMPHOMA OF THE PROSTATE - GOOD OUTCOME WITH DOXORUBICIN-BASED COMBINATION CHEMOTHERAPY [J].

SARRIS, A ;

DIMOPOULOS, M ;

PUGH, W ;

CABANILLAS, F .

JOURNAL OF UROLOGY, 1995, 153 (06) :1852-1854

← 1 2 →